Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.720 | 0.667 | 3 | 2015 | 2019 | |||||
Alanine aminotransferase measurement
|
77 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Drug-induced neutropenia
|
54 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Rheumatoid Arthritis
|
2387 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Serum Alanine Aminotransferase Measurement
|
77 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Neoplasms
|
1644 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.030 | 1.000 | 3 | 2015 | 2019 | |||||
Sepsis
|
144 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.030 | 1.000 | 3 | 2012 | 2017 | |||||
Septicemia
|
141 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.030 | 1.000 | 3 | 2012 | 2017 | |||||
Carcinogenesis
|
355 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||
Carcinoma of lung
|
1204 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2008 | 2012 | |||||
Diabetic Nephropathy
|
238 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||
Diabetic Retinopathy
|
213 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2012 | 2019 | |||||
Liver carcinoma
|
942 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||
Malignant neoplasm of lung
|
1142 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||
Age related macular degeneration
|
663 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Asthma
|
1536 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Congestive heart failure
|
165 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Coronary Artery Disease
|
1577 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Gestational Diabetes
|
224 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Heart failure
|
201 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Laryngeal Squamous Cell Carcinoma
|
30 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Left ventricular systolic dysfunction
|
11 | 0.641 | 0.680 | 6 | 32184665 | upstream gene variant | A/G | snv | 0.15 | 0.010 | 1.000 | 1 | 2012 | 2012 |